Why PPH Keeps Working When Single Themes Break

Core Insights - The VanEck Pharmaceutical ETF (PPH) has demonstrated lower volatility compared to broader markets while maintaining competitive total returns, appealing to investors who prioritize earnings visibility and balance-sheet strength [1] Group 1 - The VanEck Pharmaceutical ETF (PPH) is positioned defensively, resulting in lower volatility than the overall market [1] - Despite its defensive nature, the ETF has not significantly lagged in total returns, indicating a balanced performance [1] - The ETF is attractive for investors focused on earnings visibility and strong balance sheets, suggesting a stable investment option in the pharmaceutical sector [1]